Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis

[1]  Xiaofeng Li,et al.  Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease , 2021, BMC immunology.

[2]  B. Lie,et al.  Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action , 2021, Frontiers in Immunology.

[3]  K. Bogunia-Kubik,et al.  Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis , 2021, Cells.

[4]  T. Kuroda,et al.  Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis , 2021, International journal of molecular sciences.

[5]  A. Balsa,et al.  Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis , 2021, Frontiers in Medicine.

[6]  Jiajie Tu,et al.  A Tale of Two Immune Cells in Rheumatoid Arthritis: The Crosstalk Between Macrophages and T Cells in the Synovium , 2021, Frontiers in Immunology.

[7]  A. Catrina,et al.  Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis , 2021, RMD Open.

[8]  Zhaohui Zheng,et al.  Dysregulation of Innate Lymphoid Cells in Patients with Active Rheumatoid Arthritis and Mice with Collagen-Induced Arthritis , 2021, Mediators of inflammation.

[9]  P. Jagodziński,et al.  Th17/Treg-Related Transcriptional Factor Expression and Cytokine Profile in Patients With Rheumatoid Arthritis , 2020, Frontiers in Immunology.

[10]  L. Alfredsson,et al.  Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity , 2020, Arthritis Research & Therapy.

[11]  V. Holers,et al.  Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift , 2020, Arthritis & rheumatology.

[12]  Émilie Narni-Mancinelli,et al.  Helper-like Innate Lymphoid Cells in Humans and Mice. , 2020, Trends in immunology.

[13]  D. van der Woude,et al.  Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology , 2019, Immunological reviews.

[14]  Matthias Schneider,et al.  Association between autoantibody level and disease activity in rheumatoid arthritis is dependent on baseline inflammation. , 2019, Clinical and experimental rheumatology.

[15]  J. Stéen,et al.  Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts , 2019, Annals of the Rheumatic Diseases.

[16]  K. Akashi,et al.  CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines , 2019, Arthritis Research & Therapy.

[17]  G. Schett,et al.  Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis , 2018, Nature Reviews Rheumatology.

[18]  Xinyu Yang,et al.  Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21 , 2018, Annals of the rheumatic diseases.

[19]  S. Wirtz,et al.  Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in Mice. , 2018, Cell reports.

[20]  B. Stockinger,et al.  Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis , 2018, Immunity.

[21]  A. Alunno,et al.  One year in review 2018: pathogenesis of rheumatoid arthritis. , 2018, Clinical and experimental rheumatology.

[22]  A. Barton,et al.  Rheumatoid arthritis , 2018, Nature Reviews Disease Primers.

[23]  S. Tas,et al.  Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis. , 2017, Journal of autoimmunity.

[24]  L. Alfredsson,et al.  Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants , 2017, Annals of the rheumatic diseases.

[25]  D. Speiser,et al.  ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence , 2017, The Journal of clinical investigation.

[26]  M. Neurath,et al.  Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells , 2017, Nature Medicine.

[27]  T. Huizinga,et al.  Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis , 2015, Annals of the rheumatic diseases.

[28]  E. Lubberts,et al.  CCR6+ Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[29]  L. Taams,et al.  The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis , 2015, Front. Immunol..

[30]  M. Boes,et al.  Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid , 2015, Arthritis & rheumatology.

[31]  Jun Wang,et al.  Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis , 2014, Journal of cellular and molecular medicine.

[32]  G. Ogg,et al.  MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion , 2014, Immunity.

[33]  J. Norris,et al.  Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. , 2013, Arthritis and rheumatism.

[34]  J. Smolen,et al.  Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity , 2012, Annals of the rheumatic diseases.

[35]  J. Rocklöv,et al.  Clinical and Epidemiological Research , 2022 .

[36]  Göran Hallmans,et al.  Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis , 2011, Arthritis research & therapy.

[37]  J. Rocklöv,et al.  Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[38]  Kyung-Su Park,et al.  IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. , 2010, Immunology letters.

[39]  J. Benito,et al.  Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to Disease Activity Score-28 , 2009, Autoimmunity.

[40]  Graham M Lord,et al.  In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses , 2009, Proceedings of the National Academy of Sciences.

[41]  Iain B McInnes,et al.  Evidence that cytokines play a role in rheumatoid arthritis. , 2008, The Journal of clinical investigation.

[42]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[43]  C. Gordon,et al.  Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin , 2005, Arthritis research & therapy.

[44]  G. Müller,et al.  Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. , 2000, The Journal of rheumatology.

[45]  E. Keystone,et al.  IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. , 1998, Rheumatic diseases clinics of North America.

[46]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[47]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.